Xinjuan Fan

Prof. Xinjuan Fan

Sun Yat-sen University Sixth Affiliated Hospital

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Medical Image Analysis
Verified
Journal Article
Closed access
SWShujun Wang
Shujun Wang
YZYaxi Zhu
Yaxi Zhu
LYLequan Yu
Lequan Yu
HCHao Chen
Hao Chen
HLHuangjing Lin
Huangjing Lin
PHPheng-Ann Heng
Pheng-Ann Heng

14 October 2025 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YLYuan-Tong Liu
Yuan-Tong Liu
YWYun-Long Wang
Yun-Long Wang
SWShuo Wang
Shuo Wang
JLJia-Jun Li
Jia-Jun Li
WHWei He
Wei He
XWXiangbo Wan
Xiangbo Wan
The revolution in cancer immunotherapy, particularly through immune checkpoint inhibitors (ICIs), underscores the significant role of the tumor microenvironment (TME) in determining therapeutic outcomes. At the heart of this is the classification of tumors into “cold” and “hot”, which significantly influences the efficacy of immunotherapy. “Cold” tumors are characterized by scant immune cell infiltration and an immunosuppressive TME, which effectively evades immune detection and resists ICIs. In contrast, “hot” tumors, characterized by abundant immune cells and a proinflammatory environment, are more receptive to immunotherapeutic approaches. This review comprehensively examines the molecular and cellular foundations of the “cold” tumor phenotype, delving into the mechanisms of camouflage (impeding immune priming and infiltration), coercion (suppressing immune functions)​​, and ​​cytoprotection (resisting inflammatory death)​​ that contribute to maintaining immune silence. Furthermore, it critically evaluates emerging strategies for converting “cold” tumors to “hot”, immune-reactive entities, including the role of biomaterials in remodeling the TME to increase the effectiveness of immunotherapy. Through an in-depth exploration of these foundational mechanisms and therapeutic advancements, this review seeks to shed light on the way forward in cancer treatment, framing the transformation of “cold” tumors to “hot” tumors as a crucial approach to enhancing the reach of immunotherapy to a broader array of cancer types.

29 July 2020 in Annals of Surgical Oncology
Verified
Journal Article
Open access
PDF file
LSLizhi Shao
Lizhi Shao
ZLZhenyu Liu
Zhenyu Liu
LFLili Feng
Lili Feng
XLXiaoying Lou
Xiaoying Lou
ZLzhenhui Li
zhenhui Li
JTJie Tian
Jie Tian
Background: The aim of this work is to combine radiological and pathological information of tumor to develop a signature for pretreatment prediction of discrepancies of pathological response at several centers and restage patients with locally advanced rectal cancer (LARC) for individualized treatment planning. Patients and Methods: A total of 981 consecutive patients with evaluation of response according to tumor regression grade (TRG) who received nCRT were retrospectively recruited from four hospitals (primary cohort and external validation cohort 1–3); both pretreatment multiparametric MRI (mp-MRI) and whole slide image (WSI) of biopsy specimens were available for each patient. Quantitative image features were extracted from mp-MRI and WSI and used to construct a radiopathomics signature (RPS) powered by an artificial-intelligence model. Models based on mp-MRI or WSI alone were also constructed for comparison. Results: The RPS showed overall accuracy of 79.66–87.66% in validation cohorts. The areas under the curve of RPS at specific response grades were 0.98 (TRG0), 0.93 (≤ TRG1), and 0.84 (≤ TRG2). RPS at each grade of pathological response revealed significant improvement compared with both signatures constructed without combining multiscale tumor information (P < 0.01). Moreover, RPS showed relevance to distinct probabilities of overall survival and disease-free survival in patients with LARC who underwent nCRT (P < 0.05). Conclusions: The results of this study suggest that radiopathomics, combining both radiological information of the whole tumor and pathological information of local lesions from biopsy, could potentially predict discrepancies of pathological response prior to nCRT for better treatment planning.

8 January 2021 in Oncogene
Verified
Journal Article
Open access
PDF file
XYXin-Ke Yin
Xin-Ke Yin
YWYun-Long Wang
Yun-Long Wang
FWFei Wang
Fei Wang
WFWei-Xing Feng
Wei-Xing Feng
SBShao-Mei Bai
Shao-Mei Bai
XWXiangbo Wan
Xiangbo Wan
Arginine methylation is an important posttranslational modification catalyzed by protein arginine methyltransferases (PRMTs). However, the role of PRMTs in colorectal cancer (CRC) progression is not well understood. Here we report that non-POU domain-containing octamer-binding protein (NONO) is overexpressed in CRC tissue and is a potential marker for poor prognosis in CRC patients. NONO silencing resulted in decreased proliferation, migration, and invasion of CRC cells, whereas overexpression had the opposite effect. In a xenograft model, tumors derived from NONO-deficient CRC cells were smaller than those derived from wild-type (WT) cells, and PRMT1 inhibition blocked CRC xenograft progression. A mass spectrometry analysis indicated that NONO is a substrate of PRMT1. R251 of NONO was asymmetrically dimethylated by PRMT1 in vitro and in vivo. Compared to NONO WT cells, NONO R251K mutant-expressing CRC cells showed reduced proliferation, migration, and invasion, and PRMT1 knockdown or pharmacological inhibition abrogated the malignant phenotype associated with NONO asymmetric dimethylation in both KRAS WT and mutant CRC cells. Compared to adjacent normal tissue, PRMT1 was highly expressed in the CRC zone in clinical specimens, which was correlated with poor overall survival in patients with locally advanced CRC. These results demonstrate that PRMT1-mediated methylation of NONO at R251 promotes CRC growth and metastasis, and suggest that PRMT1 inhibition may be an effective therapeutic strategy for CRC treatment regardless of KRAS mutation status.

15 September 2016
Verified
Journal Article
Closed access
QCQing-Hua Cao
Qing-Hua Cao
FLFang Liu
Fang Liu
ZYZu-Li Yang
Zu-Li Yang
XFXin-Hui Fu
Xin-Hui Fu
ZYZi-Huan Yang
Zi-Huan Yang
XFXinjuan Fan
Xinjuan Fan

15 November 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YWYun-Long Wang
Yun-Long Wang
WZWan-Wen Zhao
Wan-Wen Zhao
JSJie Shi
Jie Shi
XWXiang-Bo Wan
Xiang-Bo Wan
JZJian Zheng
Jian Zheng
XFXinjuan Fan
Xinjuan Fan
DNA double-strand breaks (DSBs) are the fatal type of DNA damage mostly induced by exposure genome to ionizing radiation or genotoxic chemicals. DSBs are mainly repaired by homologous recombination (HR) and nonhomologous end joining (NHEJ). To repair DSBs, a large amount of DNA repair factors was observed to be concentrated at the end of DSBs in a specific spatiotemporal manner to form a repair center. Recently, this repair center was characterized as a condensate derived from liquid-liquid phase separation (LLPS) of key DSBs repair factors. LLPS has been found to be the mechanism of membraneless organelles formation and plays key roles in a variety of biological processes. In this review, the recent advances and mechanisms of LLPS in the formation of DSBs repair-related condensates are summarized.